Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Rocket Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rocket Pharmaceuticals Inc. May 20, 202699.1%
-
Rocket Pharmaceuticals Inc. June 18, 202598.8%
-
Rocket Pharmaceuticals Inc. June 13, 202499.2%
-
Rocket Pharmaceuticals Inc. June 22, 202398.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Rocket Pharmaceuticals Inc. | Grant or award | +22,862 | — | — |
| Jun 18, 2025 | Rocket Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
Questions about Carsten Boess
What boards is Carsten Boess on?
Carsten Boess sits on the boards of Atrium Therapeutics Inc. and Rocket Pharmaceuticals Inc.
How long has Carsten Boess served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.